Kenji Iwaku Fumiko Otuka Matsuo Taniyama
10.2169/internalmedicine.56.7010
Intern Med
2017;56(3):335-339.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28154279/
Antipsychotic Agents / adverse effects Benzodiazepines / adverse effects Diabetes Mellitus, Type 1 / diagnosis Hyperglycemia / chemically induced Prediabetic State / diagnosis
Antipsychotic Agents / adverse effects Benzodiazepines / adverse effects Diabetes Mellitus, Type 1 / diagnosis Hyperglycemia / chemically induced Prediabetic State / diagnosis Case Reports Adult Benzodiazepines / administration & dosage Blood Glucose Diabetes Mellitus, Type 1 / physiopathology Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / drug therapy Humans Hyperglycemia / drug therapy Insulin / therapeutic use Male Olanzapine Prediabetic State / complications Schizophrenia / drug therapy Antipsychotic Agents Blood Glucose Insulin Benzodiazepines Olanzapine
PMC5348459
28154279
Acute-Onset Type 1 Diabetes that Developed During the Administration of Olanzapine
2017